Publication date: May 23, 2025
Newswise A National Institutes of Health (NIH)-funded study by researchers from Johns Hopkins Medicine, the Johns Hopkins Bloomberg School of Public Health and The Johns Hopkins University Whiting School of Engineering finds that neutrophils the most abundant type of white blood cells in humans may be altered by SARS-CoV-2, the virus that causes COVID-19, to cease their normal function of destroyi .. .
| Concepts | Keywords |
|---|---|
| Cancers | Blood |
| Cultured | Cov |
| Hospitalization | Covid |
| K08ai156021 | Hopkins |
| Viral | Hsieh |
| Immune | |
| Johns | |
| Mdscs | |
| Neutrophils | |
| Pd | |
| Pmn | |
| Sars | |
| Severe | |
| System | |
| Virus |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | role |
| disease | MESH | viral diseases |
| disease | MESH | cancers |
| drug | DRUGBANK | Dexamethasone |
| disease | MESH | causes |
| disease | MESH | COVID-19 |
| disease | IDO | blood |
| pathway | REACTOME | Immune System |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | IDO | infection |
| disease | MESH | complications |
| disease | MESH | death |
| disease | IDO | cell |
| disease | IDO | immune response |
| disease | MESH | infections |
| pathway | REACTOME | Programmed Cell Death |
| disease | IDO | pathogen |
| disease | MESH | influenza |
| drug | DRUGBANK | Tropicamide |
| pathway | REACTOME | Release |
| disease | MESH | Alexia |
Original Article
(Visited 1 times, 1 visits today)